Siren LLC’s Janux Therapeutics JANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-175,000
Closed -$9.37M 127
2024
Q4
$9.37M Buy
+175,000
New +$9.37M 0.41% 48